{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:40:09Z","timestamp":1790887209699,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY028106"],"award-info":[{"award-number":["EY028106"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY024932"],"award-info":[{"award-number":["EY024932"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY023295"],"award-info":[{"award-number":["EY023295"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY032518"],"award-info":[{"award-number":["EY032518"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30 EY026877"],"award-info":[{"award-number":["P30 EY026877"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001641","name":"Glaucoma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001641","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015521","name":"Stanford Maternal and Child Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013669","name":"Ionis Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018789","name":"Child Health Research Institute, University of Nebraska Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.omtn.2023.02.029","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T02:06:45Z","timestamp":1677463605000},"page":"13-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies"],"prefix":"10.1016","volume":"32","author":[{"given":"Pingting","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoliang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopa","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paymaan","family":"Jafar-Nejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Rigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangbin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7980-1649","authenticated-orcid":false,"given":"Yang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2023.02.029_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41583-020-0269-3","article-title":"Programmed axon degeneration: from mouse to mechanism to medicine","volume":"21","author":"Coleman","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.omtn.2023.02.029_bib2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1083\/jcb.200504028","article-title":"A local mechanism mediates NAD-dependent protection of axon degeneration","volume":"170","author":"Wang","year":"2005","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtn.2023.02.029_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1223899","article-title":"dSarm\/Sarm1 is required for activation of an injury-induced axon death pathway","volume":"337","author":"Osterloh","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.omtn.2023.02.029_bib4","doi-asserted-by":"crossref","first-page":"13569","DOI":"10.1523\/JNEUROSCI.1197-13.2013","article-title":"Sarm1-mediated axon degeneration requires both SAM and TIR interactions","volume":"33","author":"Gerdts","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtn.2023.02.029_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1126\/science.1258366","article-title":"SARM1 activation triggers axon degeneration locally via NAD(+) destruction","volume":"348","author":"Gerdts","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.omtn.2023.02.029_bib6","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neuron.2017.02.022","article-title":"The SARM1 toll\/interleukin-1 receptor domain possesses intrinsic NAD(+) cleavage activity that promotes pathological axonal degeneration","volume":"93","author":"Essuman","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2023.02.029_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.conb.2020.02.012","article-title":"The SARM1 axon degeneration pathway: control of the NAD(+) metabolome regulates axon survival in health and disease","volume":"63","author":"Figley","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.omtn.2023.02.029_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.conb.2021.05.004","article-title":"SARM1 signaling mechanisms in the injured nervous system","volume":"69","author":"Sambashivan","year":"2021","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.omtn.2023.02.029_bib9","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtn.2023.02.029_bib10","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1083\/jcb.200706181","article-title":"Axons of retinal ganglion cells are insulted in the optic nerve early in DBA\/2J glaucoma","volume":"179","author":"Howell","year":"2007","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtn.2023.02.029_bib11","article-title":"Primary open-angle glaucoma","volume":"2","author":"Weinreb","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.omtn.2023.02.029_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100953","article-title":"Adaptive responses to neurodegenerative stress in glaucoma","volume":"84","author":"Calkins","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtn.2023.02.029_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"Toosy","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtn.2023.02.029_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/brain\/awu335","article-title":"Vision and vision-related outcome measures in multiple sclerosis","volume":"138","author":"Balcer","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.omtn.2023.02.029_bib15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ana.22005","article-title":"Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis","volume":"67","author":"Talman","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2023.02.029_bib16","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201912047","article-title":"SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration","volume":"219","author":"Ko","year":"2020","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtn.2023.02.029_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.exer.2018.03.007","article-title":"Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury","volume":"171","author":"Fernandes","year":"2018","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtn.2023.02.029_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.cmet.2019.01.001","article-title":"RNA-targeted therapeutics","volume":"29","author":"Crooke","year":"2019","journal-title":"Cell Metabol."},{"key":"10.1016\/j.omtn.2023.02.029_bib19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/nar\/gkaa1235","article-title":"The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administration","volume":"49","author":"Jafar-nejad","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2023.02.029_bib20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cell.2020.03.023","article-title":"CRISPR-based therapeutic genome editing: strategies and in\u00a0vivo delivery by AAV vectors","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2023.02.029_bib21","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1523\/JNEUROSCI.0102-20.2020","article-title":"Mouse gamma-synuclein promoter-mediated gene expression and editing in mammalian retinal ganglion cells","volume":"40","author":"Wang","year":"2020","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtn.2023.02.029_bib22","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1038\/ncomms6416","article-title":"The mTORC1 effectors S6K1 and 4E-BP play different roles in CNS axon regeneration","volume":"5","author":"Yang","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2023.02.029_bib23","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.14908","article-title":"mTORC1 is necessary but mTORC2 and GSK3beta are inhibitory for AKT3-induced axon regeneration in the central nervous system","volume":"5","author":"Miao","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.omtn.2023.02.029_bib24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41419-018-1289-z","article-title":"AKT-dependent and -independent pathways mediate PTEN deletion-induced CNS axon regeneration","volume":"10","author":"Huang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omtn.2023.02.029_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fncel.2020.00109","article-title":"Longitudinal morphological and functional assessment of RGC neurodegeneration after optic nerve crush in mouse","volume":"14","author":"Li","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.omtn.2023.02.029_bib26","article-title":"A reversible silicon oil-induced ocular hypertension model in mice","volume":"153","author":"Zhang","year":"2019","journal-title":"JoVE"},{"key":"10.1016\/j.omtn.2023.02.029_bib27","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.45881","article-title":"Silicone oil-induced ocular hypertension and glaucomatous neurodegeneration in mouse","volume":"8","author":"Zhang","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.omtn.2023.02.029_bib28","doi-asserted-by":"crossref","first-page":"9052","DOI":"10.1038\/s41598-021-88690-x","article-title":"Chronic mild and acute severe glaucomatous neurodegeneration derived from silicone oil-induced ocular hypertension","volume":"11","author":"Fang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2023.02.029_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.329","article-title":"Neuroprotection by eIF2alpha-CHOP inhibition and XBP-1 activation in EAE\/optic neuritiss","volume":"8","author":"Huang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omtn.2023.02.029_bib30","doi-asserted-by":"crossref","first-page":"754651","DOI":"10.3389\/fncel.2021.754651","article-title":"Neuronal NMNAT2 overexpression does not achieve significant neuroprotection in experimental autoimmune encephalomyelitis\/optic neuritis","volume":"15","author":"Liu","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.omtn.2023.02.029_bib31","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.neuron.2022.06.022","article-title":"Single-cell transcriptome analysis of regenerating RGCs reveals potent glaucoma neural repair genes","volume":"110","author":"Li","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2023.02.029_bib32","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1167\/iovs.14-13943","article-title":"Robust mouse pattern electroretinograms derived simultaneously from each eye using a common snout electrode","volume":"55","author":"Chou","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtn.2023.02.029_bib33","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1750-3639.2010.00401.x","article-title":"Wallerian degeneration: a major component of early axonal pathology in multiple sclerosis","volume":"20","author":"Dziedzic","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.omtn.2023.02.029_bib34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrn3609","article-title":"Axon-soma communication in neuronal injury","volume":"15","author":"Rishal","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.omtn.2023.02.029_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.07.002","article-title":"Axon injury signaling and compartmentalized injury response in glaucoma","volume":"73","author":"Syc-Mazurek","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtn.2023.02.029_bib36","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.4103\/1673-5374.193225","article-title":"Axon injury induced endoplasmic reticulum stress and neurodegeneration","volume":"11","author":"Hu","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.omtn.2023.02.029_bib37","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.neuron.2015.02.017","article-title":"Subtype-specific regeneration of retinal ganglion cells following axotomy: effects of osteopontin and mTOR signaling","volume":"85","author":"Duan","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2023.02.029_bib38","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.neuron.2019.11.006","article-title":"Single-cell profiles of retinal ganglion cells differing in resilience to injury reveal neuroprotective genes","volume":"104","author":"Tran","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2023.02.029_bib39","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.neuron.2019.05.044","article-title":"Thrombospondin-1 mediates axon regeneration in retinal ganglion cells","volume":"103","author":"Bray","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2023.02.029_bib40","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.neuron.2022.06.002","article-title":"Overlapping transcriptional programs promote survival and axonal regeneration of injured retinal ganglion cells","volume":"110","author":"Jacobi","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2023.02.029_bib41","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/nar\/gkl1071","article-title":"Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals","volume":"35","author":"Swayze","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2023.02.029_bib42","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/nar\/gkaa031","article-title":"Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotides","volume":"48","author":"\u00d8stergaard","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2023.02.029_bib43","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1523\/JNEUROSCI.3709-15.2016","article-title":"Rescue of glaucomatous neurodegeneration by differentially modulating neuronal endoplasmic reticulum stress molecules","volume":"36","author":"Yang","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtn.2023.02.029_bib44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneumeth.2017.04.003","article-title":"Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL\/6 mice for the longitudinal study of pathology and repair","volume":"284","author":"Hasselmann","year":"2017","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.omtn.2023.02.029_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107710","article-title":"Efficient determination of axon number in the optic nerve: a stereological approach","volume":"186","author":"Koschade","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtn.2023.02.029_bib46","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.exer.2015.05.008","article-title":"Electrophysiological assessment of retinal ganglion cell function","volume":"141","author":"Porciatti","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtn.2023.02.029_bib47","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.ymthe.2022.01.035","article-title":"NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function","volume":"30","author":"Fang","year":"2022","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253123000495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253123000495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:54:22Z","timestamp":1778838862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253123000495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":47,"alternative-id":["S2162253123000495"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2023.02.029","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2023.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}]}}